Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| DMK Pharmaceuticals Corporation | DMK | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,232 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,232 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0,177 - 1,50 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 0,232 | USD |
Finanzwerte DMK
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 2,34M | - | - | - | -821,29 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News DMK Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 21.3.2024 | 19:23 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security.. |
| 07.2.2024 | 23:19 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.2.2024 | 16:04 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 05.2.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31.1.2024 | 23:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23.1.2024 | 23:23 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 23.1.2024 | 23:22 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03.1.2024 | 23:03 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 03.1.2024 | 23:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03.1.2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.12.2023 | 18:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.12.2023 | 14:15 | GlobeNewswire Inc. | DMK Pharmaceuticals Regains Full Rights to Commercialize.. |
Forum DMK Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
DMK Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,51 | 1,04 | 0,177 | 0,5376824 | 1.100.103 | -0,278 | -54,51% |
| 1 Jahr | 0,7261 | 1,50 | 0,177 | 0,6419828 | 1.370.892 | -0,4941 | -68,05% |
| 3 Jahre | 0,7261 | 1,50 | 0,177 | 0,6419828 | 1.370.892 | -0,4941 | -68,05% |
| 5 Jahre | 0,7261 | 1,50 | 0,177 | 0,6419828 | 1.370.892 | -0,4941 | -68,05% |
